HHLA2 and nonpapillary renal cell carcinoma: The positive expression of human endogenous retrovirus-H long terminal repeat-associating protein 2 (HHLA2), a new member of the B7 family, has been associated with a significantly shorter OS and progression-free survival (PFS) in clear cell renal cell carcinoma (ccRCC).